We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

198 hedge funds and large institutions have $2.69B invested in Ariad Pharmaceuticals Inc in 2013 Q2 according to their latest regulatory filings, with 198 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more call options, than puts

Call options by funds: $16M | Put options by funds: $15.8M

Holders
198
Holders Change
+198
Holders Change %
–
% of All Funds
6.46%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.16%
New
198
Increased
–
Reduced
–
Closed
–
Calls
$16M
Puts
$15.8M
Net Calls
+$187K
Net Calls Change
+$187K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of Montreal
76
Bank of Montreal
Ontario, Canada
$3.02M +$3.06M +172,634 New
RhumbLine Advisers
77
RhumbLine Advisers
Massachusetts
$3M +$3.04M +171,370 New
BG
78
BlackRock Group
United Kingdom
$3M +$3.04M +171,328 New
Swiss National Bank
79
Swiss National Bank
Switzerland
$2.9M +$2.94M +165,600 New
PAMU
80
Pictet Asset Management (UK)
United Kingdom
$2.75M +$2.79M +157,100 New
Susquehanna International Group
81
Susquehanna International Group
Pennsylvania
$2.74M +$2.78M +156,769 New
SONJCPFA
82
State of New Jersey Common Pension Fund A
New Jersey
$2.62M +$2.66M +150,000 New
State of Wisconsin Investment Board
83
State of Wisconsin Investment Board
Wisconsin
$2.56M +$2.59M +146,330 New
PCA
84
Private Capital Advisors
Connecticut
$2.23M +$2.26M +127,600 New
NFA
85
Nationwide Fund Advisors
Ohio
$2.2M +$2.23M +125,700 New
Allianz Asset Management
86
Allianz Asset Management
Germany
$2.18M +$2.21M +124,400 New
WMSA
87
Weiss Multi-Strategy Advisers
New York
$2.1M +$2.13M +120,000 New
VOYA Investment Management
88
VOYA Investment Management
Georgia
$1.7M +$1.72M +97,242 New
Barclays
89
Barclays
United Kingdom
$1.63M +$1.65M +92,915 New
State Farm Mutual Automobile Insurance
90
State Farm Mutual Automobile Insurance
Illinois
$1.51M +$1.53M +86,200 New
IRF
91
IBM Retirement Fund
New York
$1.5M +$1.52M +85,738 New
Los Angeles Capital Management
92
Los Angeles Capital Management
California
$1.44M +$1.46M +82,525 New
STC
93
SEI Trust Company
Pennsylvania
$1.4M +$1.42M +79,985 New
BIM
94
BlackRock Investment Management
Delaware
$1.34M +$1.35M +76,434 New
MCM
95
Moore Capital Management
New York
$1.31M +$1.33M +75,000 New
Fidelity International
96
Fidelity International
Bermuda
$1.26M +$1.28M +72,260 New
SCA
97
SAC Capital Advisors
Connecticut
$1.25M +$1.27M +71,450 New
FSA
98
Franklin Street Advisors
North Carolina
$1.2M +$1.22M +68,696 New
CC
99
Curian Capital
Colorado
$1.08M +$1.09M +61,513 New
RNS
100
Robert N. Shapiro
$1.01M +$1.02M +57,753 New
2 3
4
5 6

ARIA Hedge Fund Activity: Q2 2013 in Review

198 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q2 2013, worth a combined $2.69B.

Buyers outnumbered sellers: 198 funds opened new ARIA positions and 0 closed out — a net gain of 198 holders — while 0 added to existing stakes and 0 trimmed.

  • 198 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $2.69B of Ariad Pharmaceuticals Inc stock for Q2 2013.
  • 198 funds opened new Ariad Pharmaceuticals Inc positions in Q2 2013 and 0 closed out, a net change of +198 holders.

Based on aggregated 13F filings for Q2 2013.